Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, April 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Anti-GABAB1 Receptor Antibody from AbboMax
Thursday, December 19, 2013
Recent progress in neuroscience research from the Company.

Tecan’s Cavro® Air Displacement Pipettor
Wednesday, December 11, 2013
Proves ideal for new microbiology application.

Cell Therapy Company Uses TAP’s Fill-It Automated Cryovial Processing System
Thursday, December 05, 2013
To rapidly produce consistent cancer immunotherapy batches and cell banks.

JHL Biotech Selects GE’s FlexFactory™ Biomanufacturing Platform for Taiwan Facility
Tuesday, December 03, 2013
New manufacturing platform will follow cGMP and be fully operational by the end of 2013.

JHL Biotech Selects GE’s FlexFactory™ Biomanufacturing Platform for Taiwan Facility
Tuesday, December 03, 2013
GE Healthcare has completed installation of its FlexFactory™ biomanufacturing platform at JHL Biotech’s Research Center and manufacturing plant in Hsinchu, Taiwan.

Molecular Devices Announces Next-Generation SpectraMax MiniMax 300 Imaging Cytometer
Tuesday, December 03, 2013
Sensitive, flexible, field-upgradeable system supports a wide range of applications.

Enhanced General Purpose Centrifuge Product Line Increases Capacity and Flexibility
Tuesday, December 03, 2013
New enhanced general purpose centrifuge product line offers clinical and life science researchers the ability to spin more samples in a single run while maximizing critical lab space.

Cellexus Launches the New CellMaker PLUS
Friday, November 29, 2013
A highly flexible, robust single-use bioreactor system with full pH and DO control to provide high ODs and yields of soluble protein.

Direvo Completes Laboratory Scale Development of Low Cost Lactic Acid Production Technology
Tuesday, November 26, 2013
BluCon® technology offers consolidated bioprocesses for production of biofuels and biobased chemicals.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 404
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv